Novo Nordisk A/S (NYSE:NVO)

56.48
Delayed Data
As of May 29
 -0.64 / -1.12%
Today’s Change
41.72
Today|||52-Week Range
57.70
+33.46%
Year-to-Date

Today’s Trading

Previous close57.12
Today’s open56.32
Day’s range55.77 - 56.71
Volume2,328,616
Average volume (3 months)1,584,892
Market cap$114.6B
Dividend yield1.35%
Data as of 4:05pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+14.60%
Revenue growth (last year)+5.60%
P/E ratio4.9
Price/Sales7.05
Price/Book22.62

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-4.55-6.58%
GSKGlaxoSmithKline-0.42-0.94%
ABBVAbbVie-0.88-1.30%
ACTActavis-6.27-2.00%
Data as of 4:05pm ET, 05/29/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.47
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Gladsaxe, Capital Region

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers